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Objectives. This study sought to determine whether noninvasive
quantification of coronary calcium is comparable to selective
coronary angiography in measuring the effect of cardiovascular
risk factors on coronary atherosclerosis.
Background. Electron beam computed tomography (EBCT)
allows the delineation of anatomic coronary atherosclerotic dis-
ease and may be useful for noninvasively defining the role of
established and new cardiovascular risk factors in selected patient
groups.
Methods. A total of 211 consecutive patients, 26 to 79 years old,
referred for evaluation of suspected or recently diagnosed coro-
nary artery disease were examined. Selective coronary angiogra-
phy was used to define five angiographic disease categories:
normal coronary arteries, nonobstructive disease and one-, two-
or three-vessel disease. EBCT was used to calculate coronary
calcium scores, and cardiovascular risk, including lipid variables
and fibrinogen levels, was assessed.
Results. Coronary calcium score and angiographic disease
severity categories were largely predicted by identical risk factors
(i.e., age, male gender, total/high density lipoprotein cholesterol
ratio, fibrinogen) and, to a lesser degree, hypertension. Only
smoking predicted angiographic disease severity but not calcium
scores. The risk factors together explained a comparable propor-
tion of the variability in angiographic disease categories and in
calcium score quintiles (33% vs. 41%, p 5 0.16 by bootstrap
analysis). An overall risk score composed of these risk factors
separated angiographic disease categories and calcium score
quintiles with a similar area under the receiver operating char-
acteristic curve ([mean 6 SE] 0.81 6 0.03 vs. 0.83 6 0.03, p 5
NS).
Conclusions. Quantification of coronary calcium is comparable
to selective coronary angiography in measuring the effect of
established cardiovascular risk factors on coronary atherosclero-
sis. Thus, EBCT may be useful for the noninvasive evaluation of
the relations between conventional or developing cardiovascular
risk factors and coronary atherosclerosis.
(J Am Coll Cardiol 1998;31:1267–73)
©1998 by the American College of Cardiology
Coronary plaque formation is a complex consequence to
genetic, environmental, dietary and habitual risk factor expo-
sure. Acting through different mechanisms, coronary risk fac-
tors lead to endothelial injury, plaque formation and the
promotion of arterial thrombus deposition (1). These risk
factors are independent variables whose clinical impact is
based on the development or progression of atherosclerosis
(i.e., a specific pathophysiologic dependent variable) (2). With
regard to a more accurate definition of coronary artery disease,
the evaluation of risk factor associations with measurements of
anatomic coronary atherosclerotic disease offers some advan-
tages over clinical end points, such as myocardial infarction or
sudden cardiac death (2,3). Selective coronary angiography is
the standard clinical method for measuring the extent of
anatomic coronary atherosclerotic disease. Alternative, nonin-
vasive procedures would be attractive because of the potential
for broader applications. However, currently available tech-
niques (e.g., carotid two-dimensional ultrasound) do not di-
rectly visualize the coronary arteries (2) and thus may not
always accurately reflect the coronary atherosclerotic disease
process (4,5).
Electron beam computed tomography (EBCT) permits
direct high resolution imaging of the coronary arteries in the
beating heart. EBCT currently represents the only noninvasive
method for accurate quantification of coronary artery calcium
(6–8). Coronary artery calcium has been established as a
specific expression of underlying atherosclerotic disease in
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pathologic-anatomic studies (9,10). More recently, calcifica-
tion has been suggested to represent an active, regulated
process (11–13) that can be found in stages of atherogenesis
seen in young adults (14,15). Quantification of coronary cal-
cium by EBCT has been shown to provide a measure of mural
atherosclerotic plaque burden (7,16,17), and a linear relation
between coronary calcium area determined by EBCT and
coronary plaque area has been reported (16). Thus, EBCT is of
interest as a method for the noninvasive delineation of ana-
tomic coronary atherosclerotic disease. However, the associa-
tion of risk factors with coronary calcium compared with the
standard measure of anatomic coronary atherosclerotic dis-
ease—coronary angiography—has not been examined. Conse-
quently, the usefulness of EBCT for defining the role of
established and new cardiovascular risk factors noninvasively
remains unclear. The current study was therefore undertaken
to determine whether the effect of established risk factors on
anatomic coronary atherosclerotic disease was comparable as
measured by 1) coronary angiography, and 2) quantification of
coronary calcium by EBCT in patients with suspected or
recently diagnosed coronary artery disease.
Methods
Patients. Two hundred eleven consecutive patients re-
ferred to the University Clinic Essen for coronary angiography
as part of an evaluation for coronary artery disease were
included in the study. The patients were examined between
March 1994 and March 1996 and included only clinically stable
patients scheduled to undergo elective coronary angiography
during selected periods in which the EBCT scanner was
available for this study. One hundred forty-six patients had
suspected coronary artery disease and were referred for an-
giography because of angina-like chest pain (n 5 22) or a
positive exercise test (n 5 53), or both (n 5 71). The other 65
patients had previously undergone coronary angiography (n 5
31) or a first myocardial infarction (n 5 14), or both (n 5 20),
a maximum of 12 months and a minimum of 1 month before
the current study. EBCT was performed within 1 week of
angiography. Patients concurrently receiving lipid-lowering
medications prescribed by their physicians were excluded from
investigation because of the anticipated alteration of blood
lipid variables. Additionally, patients with previous bypass
surgery, coronary stent implantation, coronary rotablation or
atherectomy were excluded because these interventions poten-
tially affect quantification of coronary calcium by EBCT.
Previous coronary angioplasty (n 5 45) was not considered an
exclusion criterion because it has been shown not to alter
EBCT calcium measurements (18).
Risk factors. Risk factor assessment included evaluation of
family history of premature myocardial infarction (occurring at
an age #55 years in a parent or sibling), past or current
smoking, diabetes mellitus, hypertension, calculation of body
mass index and the laboratory measurements described below.
Hypertension was established if standard sphygmomanometric
measurements with patients at rest in the supine position
showed systolic and diastolic blood pressure values $140 mm Hg
and $90 mm Hg, respectively, on three occasions or if patients
were receiving antihypertensive treatment, or both (19). Dia-
betes was defined as repeated blood glucose values $140 mg/dl
or the use of antidiabetic drug treatment, or both. On admis-
sion, after $12 h of fasting, blood was drawn for direct
laboratory measurements. Total cholesterol and triglycerides
were measured using enzymatic assays and the oxidase tech-
nique (Technicon Dax System, Technicon). High density li-
poprotein (HDL) cholesterol was determined by dextran
sulfate-magnesium precipitation, followed by enzymatic mea-
surement of cholesterol. Low density lipoprotein cholesterol
was determined by precipitation with polyvinyl sulfate and
ultracentrifugation (Boehringer Mannheim, Mannheim, Ger-
many). Apolipoprotein (apo) A1, apoB and lipoprotein(a)
were quantitated by nephelometry after addition of an anti-
serum (Behringwerke AG, Marburg, Germany) (20). Fibrino-
gen was measured by determining the coagulation time of
prediluted citrated plasma in the presence of a large amount of
thrombin (Behringwerke AG) and plasma glucose concentra-
tion using the glucose oxidase method. Precision (coefficients
of variations) and accuracy (deviations from target values) of
all measurements were in accordance with the legal guidelines
for medical laboratories in Germany.
Coronary angiography. Selective coronary angiography
was performed in each patient by the Judkins technique. After
intracoronary injection of nitroglycerin (0.2 mg), a minimum of
three biplane projections for the left coronary system and two
biplane projections for the right coronary artery were obtained
using a HICOR system (Siemens). Significant stenosis was
defined as lumen narrowing $50% in any vessel. Off-line
quantitative coronary angiography (MEDIS, Reiber) was used
to confirm categorization of lesions and to characterize culprit
lesions (21). The Coronary Artery Surgery Study (CASS) (22)
definition of angiographic disease categories was used. Angio-
grams were classified into one of five categories: 1) angio-
graphically normal coronary arteries, 2) lumen irregularities or
nonobstructive stenoses representing ,50% diameter reduc-
tion, 3) significant stenoses in one of the major coronary artery,
4) significant stenoses in two of the major coronary arteries,
and 5) significant stenoses in three of the major coronary
arteries or significant left main stem stenosis, or both.
EBCT. All patients gave informed consent to undergo the
EBCT examination, which was performed with a Siemens
Evolution scanner in the high resolution, single-slice mode
with continuous, nonoverlapping slices of 3-mm thickness and
an acquisition time of 100 ms. Patients were supine, and after
Abbreviations and Acronyms
apo 5 apolipoprotein
EBCT 5 electron beam computed tomography (tomographic)
HDL 5 high density lipoprotein
ROC 5 receiver operating characteristic
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localization of the main pulmonary artery, 36 to 40 slices
caudad through the apex of the heart were obtained with
electrocardiographic triggering at 80% of the RR interval. The
presence of coronary calcium was sequentially evaluated in all
levels, as previously described (17,23). The threshold for
calcific lesions was set at a CT density of 130 Hounsfield units
in an area of at least 0.52 mm2 (2 pixels, 5122 pixel matrix and
26 cm field of view) (5). A lesion score was determined by
multiplying the area of the hyperattenuating lesion with a
density factor as described by Agatston et al. (5). Calcium
scores in each of the major epicardial coronary arteries were
summed to define a total coronary artery calcium score.
Statistical analysis. Statistical analyses were performed
using SPSS (version 6.1.4, SPSS Inc.) and SAS (version 6.08,
SAS Institute) software packages and an IBM-compatible
personal computer. Results are expressed as mean value 6 SD,
unless otherwise indicated. To account for the nonnormal
distribution of total calcium scores, a log10{x 1 1} transfor-
mation was made (24). Triglyceride values were also trans-
formed to the logarithmic scale to minimize the skewness of
distributions. Total HDL cholesterol and apoA1/apoB ratios
were computed to account for the relative importance of these
lipoprotein and apoprotein subfractions (25,26).
Multiple linear regression analysis was used to examine the
independent relation of risk factors to angiographic disease
categories and calcium scores. Coronary calcium scores were
categorized into score quintiles to allow better comparisons
with the five angiographic disease categories. The main risk
factor predictors of angiographic disease categories and cal-
cium score quintiles were determined by stepwise linear re-
gression analysis, requiring alpha values of 0.05 and 0.10 for a
variable to enter and remain in the regression model. Risk
factors not remaining in the model were added to the final
model separately (in turn) to determine their partial signifi-
cance. The R2 value (the coefficient of determination) is a
measure of how well the regression model describes the data.
It was interpreted as explaining the proportion of variability in
the dependent variables (angiographic disease categories or
calcium score quintiles) accounted for by the (independent)
risk factor variables (27). A bootstrap analysis (28) was per-
formed to determine the significance of the difference in R2
values between angiographic disease categories and calcium
score quintiles. This method tries to replicate the variability in
the original sample as a sample from a larger population. Each
“bootstrap” sample is a random sample of 211 observations
from the original set of 211 observations, where the same
observation can be drawn more than once (“with replace-
ment”). Five hundred bootstrap samples were drawn, and the
R2 values for both dependent variables were calculated and
compared.
Receiver operating characteristic (ROC) curve analysis was
performed to establish how well the overall risk found in the
patients could separate angiographic disease categories on the
one hand and calcium score quintiles on the other. To delin-
eate overall risk for the ROC curve analysis, a simple risk score
was constructed by inspection of the regression analysis, as
explained in Results and the Appendix. Dichotomous angio-
graphic disease categories (no or nonobstructive disease vs.
one- to three-vessel disease) and calcium score quintiles (lower
two quintiles vs. upper three quintiles) were used. Sensitivity as
the dependent y-variable was plotted as a function of 1 2
specificity as the x-variable (equivalent to the “false positive
Table 1. Patient Characteristics: Risk Factor Variables in 211 Patients
Risk Factors
(continuous variables) Mean 6 SD Range
Median
(25th, 75th percentile) Cutpoints
No. (%) of
Patients
Age (yr) 55.8 6 10.4 26–79 56 (50, 63) $ 50 yr 152 (72%)
BMI (kg/m2) 26.2 6 3.1 18.8–36.1 25.9 (24.1, 27.9) $ 27 kg/m2 76 (36%)
TC (mg/dl) 231.6 6 48.9 101–418 230 (199, 265) $ 200 mg/dl 157 (74%)
HDL-C (mg/dl) 47.0 6 13.0 20–103 46 (38, 55) , 35 mg/dl 33 (16%)
TC/HDL-C ratio 5.3 6 1.8 2.3–11.6 5.0 (3.9, 6.1) $ 5 108 (51%)
LDL-C (mg/dl) 170.7 6 43.4 60–288 168 (138.5, 203.8) $ 130 mg/dl 169 (80%)
TGs (mg/dl) 172.9 6 90.7 51–597 155 (113, 208.5) $ 200 mg/dl 61 (29%)
ApoA1 (mg/dl)* 146.7 6 27.2 82.3–225.1 144.0 (127.5, 166.4) , 140 mg/dl 77/181 (43%)
ApoB (mg/dl)* 129.7 6 32.6 53.7–218.0 128.0 (104.0, 147.3) $ 120 mg/dl 108/181 (60%)
ApoA1/ApoB ratio* 1.2 6 0.4 0.42–2.61 1.15 (0.92, 1.44) — —
Fibrinogen (mg/dl) 339.4 6 84.7 188–719 328 (282, 384) $ 350 mg/dl 81 (38%)
Lp(a) (mg/dl) 45.9 6 32† ,10.6–147 ,10.6 (,10.6, 28.4) $ 30 mg/dl 51 (24%)
Male gender 169 (80%)
Family Hx (premature CAD) 55 (26%)
Smoking 126 (60%)
HTN 141 (67%)
DM 33 (16%)
*Measurements for only 181 (86%) of 211 patients. †Mean value for only 88 (42%) of 211 patients with lipoprotein(a)
levels above the detection limit of 10.6 mg/dl; 123 patients (58%) had lipoprotein(a) levels ,10.6 mg/dl. ApoA1 5
apolipoprotein A1; ApoB 5 apoliprotein B; BMI 5 body mass index; CAD 5 coronary artery disease; DM 5 diabetes
mellitus; HDL-C 5 high density lipoprotein cholesterol; HTN 5 hypertension; Hx 5 history; LDL-C 5 low density
lipoprotein cholesterol; Lp(a) 5 lipoprotein(a); TC 5 total cholesterol; TGs 5 triglycerides.
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rate”) to determine individual {x,y} pairs with different overall
risk. A p value , 0.05 was considered significant for all
statistical evaluations.
Results
Demographics. Patient characteristics and the distributions
of angiographic disease categories and calcium scores are
summarized in Tables 1 and 2. There was no difference in the
mean age of men versus women (56 6 10 vs. 57 6 11 years, p 5
0.48). Of the 211 patients, 126 (60%) had angiographically
significant stenoses in at least one vessel; 172 patients (81%)
had a total calcium score .0.
Risk factor associations. Independent risk factor associa-
tions with angiographic disease categories and calcium score
quintiles are given in Tables 3 and 4. Age, gender, fibrinogen
levels and the total/HDL cholesterol ratio were significantly
associated with both measures of anatomic coronary athero-
sclerotic disease. Hypertension was of borderline significance
in both models. However, smoking was associated only with
angiographic disease severity. The R2 values indicated that
33% of the variability in angiographic disease categories and
41% of the variability in calcium score quintiles were explained
by risk factors. Bootstrap analysis indicated that the proportion
of variability in calcium score quintiles explained by risk
factors, although higher than for angiographic disease catego-
ries, was not statistically different (two-tailed p 5 0.16). In
Figure 1. Independent risk factor predictors for patients with versus
those without angiographically significant stenoses. TC 5 total choles-
terol. *p , 0.05. †p , 0.001.
Table 3. Risk Factor Associations With Angiographic Disease
Severity by Multiple Linear Regression Analysis*
Variable Coeff SE T Value p Value
Age (yr) 0.045 0.0084 5.34 , 0.001
TC/HDL-C ratio 0.098 0.048 2.05 0.042
Fibrinogen (mg/dl) 0.0028 0.0010 2.74 0.0066
Male gender 0.44 0.22 2.01 0.046
Smoking 0.56 0.18 3.20 0.0016
HTN 0.35 0.18 1.93 0.055
BMI (kg/m2) 0.38
TC (mg/dl) 0.30
HDL-C (mg/dl) 0.31
LDL-C (mg/dl) 0.094
TGs (mg/dl) 0.85
ApoA1† 0.20
ApoB† 0.23
Lp(a) (mg/dl) 0.090
Family Hx 0.43
DM 0.91
*Intercept 5 22.26 (SE 0.64); T 5 23.51; p , 0.001. †Measurements of
apoA1 and apoB were available for only 181 patients. Coeff 5 coefficient; other
abbreviations as in Table 1.
Table 4. Risk Factor Associations With Electron Beam Computed
Tomographic Total Calcium Score Quintiles by Multiple Linear
Regression Analysis*
Variable Coeff SE T Value p Value
Age (yr) 0.051 0.0078 6.52 , 0.001
TC/HDL-C ratio 0.18 0.044 4.00 , 0.001
Fibrinogen (mg/dl) 0.0038 0.00095 4.01 , 0.001
Male gender 0.61 0.20 3.10 0.0024
Smoking — — — 0.54
HTN 0.34 0.17 2.02 0.045
BMI (kg/m2) 0.69
TC (mg/dl) 0.13
HDL-C (mg/dl) 0.23
LDL-C (mg/dl) 0.45
TGs (mg/dl) 0.97
ApoA1† 0.05
ApoB† 0.60
Lp(a) (mg/dl) 0.55
Family Hx 0.65
DM 0.99
*Intercept 5 22.09 (SE 0.45); T 5 24.68; p , 0.001. †Measurements of
apoA1 and apoB were available only for 181 patients. Abbreviations as in Tables
1 and 3.
Table 2. Patient Characteristics: Coronary Angiographic Findings
and Coronary Calcium Scores for 211 Study Patients
Angiographic disease category
Normal coronary arteries 59 (28%)
Nonobstructive disease 26 (12%)
One-vessel disease 61 (29%)
Two-vessel disease 31 (15%)
Three-vessel disease 34 (16%)
Calcium score
Mean 6 SD 274.2 6 424.5
Median 77.9
25th percentile 1.6
75th percentile 347.4
Range 0–2,203.5
Quintile (range)
1st 0–0.5
2nd 0.8–31.3
3rd 32.0–184.8
4th 186.7–437.4
5th 444.3–2,203.5
Data presented are number (%) of patients, unless otherwise indicated.
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Figure 1 the mean values or prevalence of the independent risk
factor predictors are compared between patients with and
patients without angiographically significant stenoses. In Fig-
ure 2 the same risk factor predictors are compared between
patients with calcium scores in the upper three quintiles and
patients with calcium scores in the lower two quintiles, with an
almost identical number of patients per group as in the two
angiographic groups in Figure 1.
When the regression models were compared, there was a
distinct similarity in the coefficients predicting angiographic
disease categories and calcium score (Tables 3 and 4). Because
the range of both the coronary disease categories and the
calcium score quintiles was one to five, the regression coeffi-
cients had a similar interpretation and could be used to
construct a simple risk score representing the overall risk that
determined the extent of anatomic coronary atherosclerotic
disease in our patients (see Appendix). ROC curve analysis
was performed to determine how well this overall risk score
could separate angiographic disease, categorized into no or
nonobstructive disease versus significant disease, and calcium
scores, categorized into the two lower quintiles versus the three
upper quintiles. Figure 3 shows that the area under the ROC
curve for angiographic disease categories was comparable to
that for calcium score quintiles (0.81 6 0.03, vs. 0.83 6 0.03,
p 5 NS by bootstrap analysis). Figure 4 shows that the overall
risk increased continuously with the five angiographic disease
categories as well as with the calcium score quintiles.
Discussion
The present investigation demonstrates that clinical mea-
sures of established cardiovascular risk factors have a very
similar relation with coronary calcium scores compared with
angiographic disease categories in symptomatic patients.
Smoking notwithstanding, five risk factors, (i.e., age, gender,
fibrinogen, the total/HDL cholesterol ratio and, to a lesser
degree, hypertension) were found to predict both measures of
anatomic coronary atherosclerotic disease to a comparable
degree. Hence, in the symptomatic cohort examined, quantifi-
cation of coronary calcium by EBCT was comparable to
coronary angiography in measuring the effect of established
risk factors on anatomic coronary atherosclerotic disease. This
finding may be of considerable importance for epidemiologic
purposes because EBCT may thus be the first noninvasive
Figure 2. Independent risk factor predictors for patients with calcium
scores in the upper three quintiles versus those with calcium scores in
the lower two quintiles. TC 5 total cholesterol. *p , 0.05. †p , 0.001.
Figure 3. ROC curve analysis for overall risk score versus coronary
angiographic findings (i.e., no or nonobstructive disease vs. significant
angiographic disease) and calcium score quintiles (i.e., lower two
quintiles vs. upper three quintiles). The sensitivity of the risk score with
reference to coronary angiographic findings or calcium score is plotted
as a function of {1 2 specificity} (equivalent to the “false positive
rate”) to determine individual {x,y} pairs with different risk scores.
The areas under the curve for coronary angiographic findings and
calcium score are presented as mean 6 SE and were not statistically
different. Both curve areas were significantly different from a random
distribution (coronary angiographic findings: p , 0.001, z 5 10.59;
calcium score: p , 0.001, z 5 10.88).
Figure 4. Overall risk score (6SD) in the five angiographic disease
categories (solid bars) versus calcium score quintiles (open bars).
Overall risk increases continuously and similarly in each category for
both angiographic disease categories and coronary calcium score quin-
tiles. *p , 0.05 (analysis of variance, Student-Newman-Keuls test).
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method that allows direct evaluation of the effects of risk
factors on coronary atherosclerosis.
Coronary calcium and atherosclerosis. Several mecha-
nisms link arterial calcification to atherosclerosis (11–13).
Cholesterol and its oxidation products accelerate coronary
calcification (12). Smaller amounts of calcium have been
shown to be present in noncomplex, lipid-rich fibromuscular
plaques (10) and in coronary lesions seen in young adults (type
III lesion) (14). More advanced type Vb/VII plaques regularly
contain calcium deposits (14,15). Although calcium quantities
are best correlated with overall coronary plaque area (16,29),
a positive correlation with stenosis severity is also seen (30),
establishing the potential for noninvasive diagnosis of coronary
stenoses (31). In contrast, even severe stenoses are occasion-
ally noncalcified as assessed by EBCT (7,17,23). Coronary
angiography very reliably detects flow-limiting stenoses. Over-
all plaque burden may be underestimated because of
mechanisms such as arterial remodeling, a diffuse distribution
of atherosclerotic disease and eccentric lesion formation
(1,32,33). In this respect, sophisticated angiographic scoring
methods seem to offer only limited incremental value
(32,34,35).
Risk factor variables. Smoking was independently associ-
ated with angiographic disease but not with coronary calcium
score. Smoking is a risk factor for coronary arterial thrombosis
irrespective of plaque morphology (36), and it may lead to
clinical symptoms at earlier stages of coronary artery disease
than in nonsmokers (37). Accordingly, smokers with a compa-
rably low coronary plaque burden and little or no calcification
may become symptomatic.
An interesting finding in our study group was the strong
independent predictive value of fibrinogen levels with respect
to both calcium scores and angiographic disease categories. It
has been previously shown that elevated fibrinogen levels
independently predict cardiovascular events (38) and angio-
graphic disease severity (39). Its role as an indicator of
inflammation notwithstanding, elevated fibrinogen levels can
be considered a major cardiovascular risk factor (40).
Study limitations. Despite substantial advances in our
knowledge in recent years, the multifactorial pathogenic mech-
anisms of atherogenesis are still incompletely understood.
Numerous coronary risk factors have been proposed. Homo-
cysteine (41) was not measured in the present investigation. It
has adverse effects on endothelium, platelets and clotting
factors, and elevated homocysteine concentrations have been
associated with premature coronary artery disease and myo-
cardial infarction. Another genetic risk factor, apoE polymor-
phism (42), was also not considered. Furthermore, recent
reports (43) have suggested that chronic infection with agents
such as Chlamydia pneumoniae may play a role in vascular
endothelial damage and atherogenesis. These and other risk
factors may account for part of the unexplained variability in
measures of coronary atherosclerosis (44). Nonetheless, to our
knowledge, our investigation represents the most comprehen-
sive risk assessment with regard to coronary calcium quantities
thus far reported.
The study group was relatively small (n 5 211), and a larger
study group might have enabled the detection of differences in
the correlations of risk factors with coronary calcium scores
versus angiographic disease categories. However, given that
there was a trend in favor of coronary calcium that might have
become more obvious in a larger sample, our main conclusions
regarding the value of coronary calcium as a measure of risk
factor effects on coronary atherosclerosis would only be
strengthened.
It should be noted that the present study examined a cohort
sample from an urban area in Germany. Extrapolation to other
patient groups may be limited, especially with regard to
smoking habits.
Clinical implications. Our results suggest that noninvasive
quantification of coronary artery calcium by EBCT may allow
for facilitated, noninvasive measurements of anatomic coro-
nary atherosclerotic disease in epidemiologic investigations.
The close link between coronary risk factors and coronary
calcium as a measure of atherosclerotic disease is also under-
scored by recent EBCT studies in symptomatic (24) and
asymptomatic (45,46) high risk patients that reported that high
calcium scores predicted death and myocardial infarction (24)
and other cardiovascular events (45,46) in these study groups.
Thus, EBCT may allow noninvasive evaluation of the relation
between conventional or developing cardiovascular risk factors
and coronary atherosclerosis.
Appendix
Overall Risk Score
The overall risk score was based on the cardiovascular risk factors that
were found to predict angiographic disease categories and calcium
scores in our patient sample and were calculated as follows:
Overall risk 5
Age
20 1
~TC!/~HDL!
10 1 1$Male%z0.5 1
Fbg
350 1 1$Smoker%z0.5
1 1$HTN%z0.7,
where Fbg 5 fibrinogen (mg/dl); HDL 5 HDL cholesterol; HTN 5
hypertension; and TC 5 total cholesterol. For a 20-year old nonsmok-
ing, nonhypertensive woman with a ratio of total cholesterol/HDL
cholesterol of 3 and a fibrinogen level of 250 mg/dl, the risk score is
2.01. For a 70-year old hypertensive man with a ratio of total
cholesterol/HDL-cholesterol of 7 and a fibrinogen level of 450 mg/dl
and who smokes, the risk score is 6.84.
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